Morgan Stanley’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Buy |
99,678
+78,032
| +360% | +$152K | ﹤0.01% | 5862 |
|
|
2025
Q1 | $47.4K | Buy |
21,646
+14,350
| +197% | +$31.4K | ﹤0.01% | 6286 |
|
|
2024
Q4 | $23.7K | Buy |
7,296
+5,629
| +338% | +$18.3K | ﹤0.01% | 6516 |
|
|
2024
Q3 | $2.17K | Hold |
1,667
| – | – | ﹤0.01% | 7117 |
|
|
2024
Q2 | $2.02K | Hold |
1,667
| – | – | ﹤0.01% | 7066 |
|
|
2024
Q1 | $3.6K | Sell |
1,667
-1,667
| -50% | -$3.6K | ﹤0.01% | 6962 |
|
|
2023
Q4 | $4.23K | Buy |
3,334
+1,667
| +100% | +$2.12K | ﹤0.01% | 7031 |
|
|
2023
Q3 | $2.32K | Hold |
1,667
| – | – | ﹤0.01% | 7100 |
|
|
2023
Q2 | $6.02K | Hold |
1,667
| – | – | ﹤0.01% | 6942 |
|
|
2023
Q1 | $6.58K | Hold |
1,667
| – | – | ﹤0.01% | 6997 |
|
|
2022
Q4 | $5K | Hold |
1,667
| – | – | ﹤0.01% | 7145 |
|
|
2022
Q3 | $9K | Hold |
1,667
| – | – | ﹤0.01% | 7107 |
|
|
2022
Q2 | $7K | Buy |
+1,667
| New | +$7K | ﹤0.01% | 7320 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8031 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8028 |
|